Contact
 

Doctors to develop anti-HIV gel for SA

Speaking at a media briefing in Cape Town, Dr. Zeda Rosenberg, CEO of the International Partnership for Microbicides, described results of the CAPRISA microbicide trial as a “huge achievement,” but emphasized that the candidate gel needs to be tested again to confirm initial findings. The story is available here:  http://www.iol.co.za/index.php?set_id=1&click_id=117&art_id=vn20100816042808750C511284

Global HIV Vaccine Enterprise, 64 Beaver Street, # 352, New York, NY 10004 | +1 212-461-3692 or toll free at +1-866-966-4483
All Content ©2005 - 2013 Global HIV Vaccine Enterprise   |   Terms of Use   |   Privacy Policy   |   Log In / My Account